Why study changes in breast cancer rates over time? How did we study these changes in breast cancer rates?

Similar documents
Prevention and Screening for Breast Cancer

BREAST CANCER SCREENING:

Breast Cancer Screening

Jeddah Breast Cancer Pilot Screening Program, KSA

CONTENTS NOTE TO THE READER...1 LIST OF PARTICIPANTS...3

Screening Mammography for Women Aged 40 to 49 Years at Average Risk for Breast Cancer

SCREENING FOR BREAST CANCER: Breast Self-Examination, Clinical Breast Examination & Mammography

Breast Cancer Screening and Treatment Mrs Belinda Scott Breast Surgeon Breast Associates Auckland

Breast Cancer Screening: Changing Philosophies in Educating Women and Teens

Breast Cancer Risk Factors 8/3/2014

Breast Screening: risks if you do and risks if you don t. Stephen W. Duffy Wolfson Institute of Preventive Medicine

SBI Breast Imaging Symposium 2016 Austin Texas, April 7, 2016

Interpretation of Breast Pathology in the Era of Minimally Invasive Procedures

BreastScreen Victoria Annual Statistical Report

Screening Overdiagnosis. Archie Bleyer, MD Department of Radiation Medicine Knight Cancer Institute at the Oregon Health & Science University

Summary. Chapter 7. Breast cancer and screening

Cancer Screening: Controversial Topics 10/27/17. Vijay Kudithipudi, MD Kettering Cancer Care Radiation Oncology

Shared Decision Making in Breast and Prostate Cancer Screening. An Update and a Patient-Centered Approach. Sharon K. Hull, MD, MPH July, 2017

General principles of screening: A radiological perspective

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

Controversies in Breast Cancer Screening

RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES

Evaluation of the Contralateral Breast in Patients with Ipsilateral Breast Carcinoma: The Role of Mammography

The Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

Andrology Services at HA Past, Present and Future. W.S.B. Yeung Department of Obstetrics and Gynaecology The University of Hong Kong

Effective Health Care Program

BREAST CANCER d an BREAST SELF EXAM

Breast Cancer Screening and Diagnosis

Programme Report

Clinicopathological correlates in a cohort of Hong Kong breast cancer patients presenting with screen-detected or symptomatic disease

Cancer Screening: Evidence, Opinion and Fact Dialogue on Cancer April Ruth Etzioni Fred Hutchinson Cancer Research Center

Breast Cancer Diagnosis, Treatment and Follow-up

Should I Get a Mammogram?

THE PATIENT VOICE IN CHINA:

Cancer research investment should shift from late stage treatment to early stage detection No!

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

How often should I get a mammogram?

Mammography and Other Screening Tests. for Breast Problems

Breast health and screening

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF

Minimizing Errors in Diagnostic Pathology

Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018)

Cancer Treatment Services in Public Hospitals

Cancer in transition: the human development index and the global disease burden 2008 and Freddie Bray

Factors affecting the palpability of breast lesion by self-examination

Robert Burton. Globalization of Cancer and the Challenge of Improving Cancer Cure and Care in Developing Countries EQUATOR. Monash University.

Variation of Benefits and Harms of Breast Cancer Screening With Age

Cancer Survivors: - Asian Perspective

Screening Mammography Policy and Politics. Kevin L. Piggott, MD, MPH August 29, 2015

Enhanced Surveillance vs. Risk Reducing Mastectomy for BRCA+ Patients with Advanced Ovarian Cancer: Surgical Futility or Valuable Prevention?

Untangling the Confusion: Multiple Breast Cancer Screening Guidelines and the Ones We Should Follow

NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

6. SUMMARY. 6.1 Breast cancer

Life expectancy in the United States continues to lengthen.

Steven Jubelirer, MD Clinical Professor Medicine WVU Charleston Division Senior Research Scientist CAMC Research Institute

Breast Cancer. Facts & Fiction

The Debate: Is screening s effect on mortality significant? Cancer incidence/death/ gender US

Oncology in Emerging Markets

BreastScreen Victoria Annual Statistical Report

Breast cancer: an update

BAYLOR SCOTT & WHITE HEALTH GENETICS QUESTIONNAIRE PATIENT INFORMATION

LOWER-INCOME DISTRICTS RECORDED HIGHER RATES OF ADVANCED STAGE BREAST CANCER CASES AND LOWER BREAST SCREENING RATES

Faster Cancer Treatment Indicators: Use cases

Public Health Agency NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN QUALITY ASSURANCE REFERENCE CENTRE

NHS breast screening Helping you decide

Cite this article as: BMJ, doi: /bmj f (published 8 March 2005)

Variations in Breast Cancer Incidence and Mortality. M. Espié Centre des maladies du sein Hôpital St LOUIS APHP

Northern Ireland breast screening. Helping you decide

BR 1 Palpable breast lump

Prostate Cancer Screening Where are we? Prof. Bob Steele Professor of Surgery, University of Dundee Independent Chair, UK NSC

Epidemiology of Lung Cancer: Implications for screening and prevention

- The University of. - Student. Western Australia, Crawley, Western Australia

The Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012

Northern Ireland breast screening. Helping you decide

Information Services Division NHS National Services Scotland

3/21/11 Tabar et al Lancet 2003;361:

What is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*

The U.S. Preventive Services Task Force (USPSTF) CLINICAL GUIDELINE

Breast Density. Information for Health Professionals

The Northern Ireland breast screening programme

Breast Cancer Screening

Emerging Risk: Cancer Products and Associated Risks

/Webpages/zhang/chinese-full full- program.htm

Information Services Division NHS National Services Scotland

Breast Cancer. Common kinds of breast cancer are

National Cancer Statistics in Korea, 2014

National Breast Cancer Audit next steps. Martin Lee

The Greater Bay Area Cancer Registry Annual Report: Incidence and Mortality Review,

Overview of 2010 Hong Kong Cancer Statistics

Neoadjuvant therapy a new pathway to registration?

Examine breast cancer trends, statistics, and death rates, and impact of screenings. Discuss benefits and risks of screening

Breast Cancer Screening

Rethinking Breast Cancer Screening

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging

Nasopharyngeal carcinoma time lapse before diagnosis and treatment

MemorialCare Breast Center at Long Beach Memorial

EARLY DETECTION. Screening Mammography Programs. Knowledge Summary

Overdiagnosis of Breast Cancer: Myths and Facts

Transcription:

Breast Cancer Trends in Hong Kong: What are the Implications for Screening, Diagnosis and Management in All Chinese Women? GM Leung, TH Lam, TQ Thach, AJ Hedley Department of Community Medicine, HKU W Foo, Queen Elizabeth Hospital and Hong Kong Cancer Registry J Kong, Pamela Youde Nethersole Eastern Hospital R Fielding, WWT Lam Centre for Psycho-Oncological Research and Teaching, Department of Community Medicine, HKU January 16, 2003 Why study changes in breast cancer rates over time? To identify possible changes in population risk factors in Hong Kong To inform and predict future trends in Hong Kong and the rest of Asia How did we study these changes in breast cancer rates? Using data from the HK Cancer Registry Statistical techniques to separate out the influences of: - The ageing population - Changes in the external environment - Generation effects i.e. different risks for women born in different years (between 1900 and 1960) RISK Age-standardised incidence per 100,000 0 10 20 30 40 50 Are breast cancer rates increasing in Hong Kong? 37% increase over 27 years 1973-75 1976-78 1979-81 1982-84 1985-87 1988-90 1991-93 1994-96 1997-99 Year Average annual percentage change (%) -1 0 1 2 3 4 Which age groups have had an increase? What accounted for the increase in breast cancer rates? Most of the changes were due to generation effects - i.e. women s increased risk of breast cancer was a result of their birth date For example, we observed a 2-fold difference between women born in 1900 and 1960 30-39 40-49 50-59 60-69 70-79 80+ All ages Age (years) 1

RISK Relative risk (log scale) 1 2 3 Increasing risk: the generation effect What factors are reflected in the generation effects relevant to HK? Late marriage, low fertility and late age of first pregnancy A more affluent lifestyle Low physical activity levels Increasing obesity Early puberty 1900 1905 1910 1915 1920 1925 1930 1935 1940 1945 1950 1955 1960 1965 Central year of birth What are the implications of these findings for: Mass population screening by: Mammography? breast self examination? Diagnosis & management: medical treatment? psychological aspects? Cancer Screening: Where are we now in HK? In Shanghai, no survival benefit for regular breast self-examination No HK data on the effectiveness of mass screening by mammography All studies on screening mammography undertaken only in Western countries We therefore carried out an evidencebased review of the Western literature What do Western studies show? Risk ratio HIP 0.87 Malmo 0.81 Ostergotland 0.75 Kopparberg 0.58 Edinburgh 0.86 CNBSS II 1.02 Stockholm 0.74 Gothenburg 0.81 Overall 0.80 Can the test prevent death due to breast cancer in Western women? Western evidence shows a 20% benefit of delayed death from breast cancer (but not necessarily all causes) Benefit 0.6 0.8 1 1.2 Harm Risk ratio 2

Breast cancer rates in different countries Is Hong Kong in a transition? China South Central Asia South Eastern Asia Western Asia Japan Hong Kong Western Europe Nothern Europe LOW HIGH Australia/ New Zealand North America 0 10 20 30 40 50 60 70 80 90 100 Age-Standardised Incidence (per 100,000) in 1990 What are the implications of a relatively low breast cancer rate? Low accuracy of positive test results Of every 100 women who get a positive result from the screening test, at least 86 and as many as 98 will turn out to be Source: International Agency for Research on Cancer FALSE POSITIVES Why are false positives a problem for women? Positive screen results invariably lead to further confirmatory testing Such as fine needle aspiration or even open biopsy (surgery) Possible complications, including haematoma (bleeding) and wound infection, occur at a rate of 8%-10% Unnecessary anxiety and psychological burden for false positive women How many women do we need to screen to save one from dying of breast cancer? (Number Needed to Screen or NNS) If we screen all women aged 50 and over in HK annually for 10 years, assuming 100% uptake and follow-up, and assuming the 20% risk reduction seen in Western women: NNS for HK women = 1,302 US women = 666 3

Screened = 100,000 Natural History of Breast Cancer - the dilemma of ductal carcinoma in situ (DCIS) Positive = 10,370 False positive = 8,980 DCIS are early cancers confined to the milk ducts of the breast We currently do not know their clinical significance BUT if we find them, they are surgically removed (precautionary principle) Lives saved = 77 Complications = 134 Are DCIS common? US SEER programme (Cancer Registry) DCIS incidence 200% higher than expected in 1992 when mammography became widespread, based on trends in 1973-83 Ernster et al. JAMA. 1996;275:913-8 Kwong Wah Hospital mammography programme 53% of all abnormal screens were DCIS on trends in 1973-83 Lau et al. Aust NZ J Surg. 1998;68:707-11 What is the prognosis of DCIS? The absolute risk of breast cancer death among women with DCIS - 1.9% in 10 yrs Ernster et al. Arch Intern Med. 2000;160:953-8 Excellent survival of women with DCIS is probably NOT due to screening (but a combination of lead time and length bias) Miller AB et al. J Natl Cancer Inst. 2000;92:1490-9. 4 key differences between Chinese and Western women Ethnic differences in breast cancer risk, value of a positive screening test low in Chinese High number needed to screen to yield cancer-related mortality in Chinese Uncertain natural history of breast cancer - the DCIS dilemma We need to focus on the balance of benefit, harm and cost Conclusions (1) Currently insufficient evidence to justify population-based, mass screening by mammography in Chinese women However, women at high risk for the disease need careful individual clinical assessment e.g. - previous breast cancer - 2 first degree relatives - previous abnormal biopsy 4

Conclusions (2) Diagnostic vs Screening mammography breast imaging by mammography is a very useful tool for diagnosis of symptomatic patients but it is a poor instrument for screening asymptomatic Chinese women Conclusions (3) Resources that may be allocated for mass screening would be better directed at: Raising public awareness ( Be Breast Aware ) Promoting medical attention when symptoms appear Enhancing treatment services waiting time chemotherapy surgery radiotherapy psychological counselling Incidence of Top 10 Cancers in Female Age-Standaradized Rate 45.0 40.0 35.0 30.0 25.0 20.0 15.0 10.0 5.0 Breast Lung Colon Rectum Cervix Stomach Liver Corpus Ovary NPC The only documented effective method of early detection of breast cancer is mammographic screening..;.but screening is not the only way to reduce mortality - 1983 1985 1987 1989 1991 1993 1995 1997 1999 Year Investment: Mammographic units Trained radiologists Trained surgeons and pathologists Administrative system Education and Promotion Better investment: Trained surgeons and pathologists To strengthen definitive treatment To strengthen adjuvant treatment Conclusion: As demonstrated by the HKU report, alarming increase in incidence (but actually decreasing mortality) Conditions NOT RIPE to introduce mammographic screening - disproportionately high demand on resources, wasted efforts of screened women Need for a risk model to define high risk group more cost-effective in screening for the purpose of reducing mortality 5

Impacts of diagnosis and treatment on breast cancer patients High level of physiological and psychological distress ~ 1 patient in every 2 experiences anxiety and depression Delayed adjustment Increased family burden Increased use of medical services Local studies show psychosocial impact of breast cancer Diagnosis and treatment is a prolonged, multistage process that is very stressful Breast cancer diagnosis is profoundly shocking Women choose more extreme surgery to quicken return to normal life Psychosocial adjustment is better in women - who are more satisfied with participation in decisions about treatment -when treatment outcomes match expectations Implications More attention should be given to consultations in breast cancer Careful and continuing support is needed to help women make several treatment decisions After treatment rehabilitation can be developed to support women s return to their normal lives New development in Department of Community Medicine, HKU Mission: Identify key psychosocial and behavioural issues in the prevention and treatment of and adaptation to cancers in Chinese and other Asian people Offer evidence-based training to health workers caring for people with cancer Develop psychosocial clinical practice guidelines based on local research, emphasis on patientcentred care to address these issues 6